Press release

Class Action Lawsuit Filed Against Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm


ATLANTA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Brainstorm Cell Therapeutics Inc. ("Brainstorm Cell" or the "Company") (NASDAQ:BCLI). The lawsuit alleges Brainstorm Cell made false or misleading statements and/or omitted material adverse information regarding the Company's business, operations, and prospects, including: (1) Brainstorm Cell downplayed the severity of the FDA's refusal to file letter; and (2) Brainstorm Cell continued to conceal the risks associated with the submission of its Biologics License Application for ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


 disclaimer_press_release